HOME >> BIOLOGY >> NEWS
Medical research scientists make ethical value judgments in research

NEW YORK (May 14, 2007) -- Medical research scientists in public health and other areas routinely make ethical value judgments, even if they're not aware of it, according to a new Weill Cornell Medical College research study. And not only do these judgments not lead to bias necessarily, but they can make for better research.

Published in the current issue of European Journal of Epidemiology, the paper finds that the framing of the research question, identification of the problem, as well as the design and methodology of the study are all subject to value judgments by investigators.

To illustrate this point, the study focuses on how value judgments are made in epidemiological research of racial health disparities.

"Epidemiologists must endorse particular public policy aims of the research in order to make methodological decisions throughout the research process. In the case of research into racial disparities, the researcher decides how to define race -- whether by genetic markers or by census data. Both definitions are valid on their own, but in deciding which one to use, the scientist makes value assumptions about which would best promote the social aims of the research, such as eliminating racial disparities," says Dr. Inmaculada de Melo-Martn, the study's co-author and associate professor in the Division of Medical Ethics in the Department of Public Health at Weill Cornell Medical College.

"Also, scientists make value judgments in deciding which areas of research to pursue. For example, if the recommendations likely to result from additional genetic research are already part of standard medical practice, or if the new drugs resulting from genetic research would likely be too expensive for minority groups, then genetic research may not be the most effective way of trying to decrease racial health disparities," notes Dr. de Melo-Martn.

"In fact, many medical research scientists make these value judgments without
'"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
14-May-2007


Page: 1 2

Related biology news :

1. Ossurs PROPRIO FOOT takes the Gold 2007 Medical Design Excellence Award
2. Innovative smallpox vaccine research study to be conducted at Case Medical Center
3. Vitamin extends life in yeast, Dartmouth Medical School researchers find
4. Ossurs Proprio Foot walks away with 2007 Medical Design Excellence Award
5. University of Minnesotas 6th annual Design of Medical Devices Conference to be held April 17-19
6. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
7. Burnham Institute for Medical Research announces affiliation with UC Santa Barbara
8. Yale scientist honored with Keio University Medical Science Prize
9. American College of Medical Genetics -- 2007 Annual Clinical Genetics Meeting Announcement
10. Breast Cancer Month story tips from Georgetown University Medical Center
11. Columbia University Medical Center receives major new NIH Clinical Science investment funds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... HOUSTON (PRWEB) , ... August 25, 2020 , ... ... it made Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most ... list in 2019 as well, and for this year’s list, reported three-year revenue growth ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, ... that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational ... the treatment of severe COVID-19. Approval of this IND allows Sentien to initiate ...
(Date:8/21/2020)... ... August 19, 2020 , ... ... expo uniting life science, data science, informatics and IT leaders goes VIRTUAL and ... period of uncertainty and change, Bio-IT takes the leadership role of keeping our ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners ... has announced the placement of Julianne Averill , CPA, as Chief Financial ... financial operations and implementing key business strategies to accelerate Alveo’s growth as the ...
(Date:8/15/2020)... (PRWEB) , ... August 13, 2020 , ... True ... the creation of its Scientific Advisory Board (SAB) to research the medical potential of ... can be enhanced when combined with terpenes. The board is focused on expanding the ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society ... Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of ... a consortium of academic research centers in the United States and Europe with ...
(Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
Breaking Biology Technology:
Cached News: